These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 25365592)
21. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population. Reeves D; Liu CY J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307 [TBL] [Abstract][Full Text] [Related]
22. Venous thromboembolism in hospitalized patients: an updated analysis of missed opportunities for thromboprophylaxis at a university-affiliated tertiary care center. Ma KA; Cohen E; Kahn SR Vasc Med; 2014 Oct; 19(5):385-91. PubMed ID: 25074356 [TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism prophylaxis guideline compliance: a pilot study of augmented medication charts. Cunningham R; Murray A; Byrne JS; Hammond L; Barry M; Mehigan D; Sheehan S Ir J Med Sci; 2015 Jun; 184(2):469-74. PubMed ID: 25023126 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease. Barclay SM; Jeffres MN; Nguyen K; Nguyen T Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808 [TBL] [Abstract][Full Text] [Related]
25. Effects of Computerised Clinical Decision Support on Adherence to VTE Prophylaxis Clinical Practice Guidelines among Hospitalised Patients. Titi MA; Alotair HA; Fayed A; Baksh M; Alsaif FAA; Almomani Z; Atallah M; Alsharif AF; Jamal AA; Amer YS Int J Qual Health Care; 2021 Mar; 33(1):. PubMed ID: 33647102 [TBL] [Abstract][Full Text] [Related]
26. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center. Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933 [TBL] [Abstract][Full Text] [Related]
27. A 10-year analysis of venous thromboembolism on the surgical service: the effect of practice guidelines for prophylaxis. Shackford SR; Rogers FB; Terrien CM; Bouchard P; Ratliff J; Zubis R Surgery; 2008 Jul; 144(1):3-11. PubMed ID: 18571579 [TBL] [Abstract][Full Text] [Related]
28. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients. Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050 [TBL] [Abstract][Full Text] [Related]
31. Disease burden and unmet needs for prevention of venous thromboembolism in medically ill patients in Europe show underutilisation of preventive therapies. Khoury H; Welner S; Kubin M; Folkerts K; Haas S Thromb Haemost; 2011 Oct; 106(4):600-8. PubMed ID: 21833448 [TBL] [Abstract][Full Text] [Related]
33. Incidence of Venous Thromboembolism, Risk Factors and Prophylaxis in Hospitalized Patients in the South West Region of Cameroon. Nkoke C; Tchinde Ngueping MJ; Atemkeng F; Teuwafeu D; Boombhi J; Menanga A Vasc Health Risk Manag; 2020; 16():317-324. PubMed ID: 32801728 [TBL] [Abstract][Full Text] [Related]
34. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19. Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129 [TBL] [Abstract][Full Text] [Related]
35. Considerations for pharmacologic thromboprophylaxis following inpatient brachytherapy for gynecologic malignancies. McAlarnen LA; Small C; Tostrud L; Pan AY; Erickson B; Bedi M; Bradley WH Brachytherapy; 2023; 22(5):630-639. PubMed ID: 37394350 [TBL] [Abstract][Full Text] [Related]
36. Anticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients. Wan T; Garland SJ; Drury CT; Lambert J; Yoon J; Chan M Thromb Res; 2024 Jul; 239():109036. PubMed ID: 38776611 [TBL] [Abstract][Full Text] [Related]
37. Prevention of venous thromboembolism in medical patients and outpatients. Stashenko GJ; Tapson VF Nat Rev Cardiol; 2009 May; 6(5):356-63. PubMed ID: 19377498 [TBL] [Abstract][Full Text] [Related]
38. Trends in venous thromboembolism prophylaxis in gynecologic surgery for benign and malignant indications. Syeda SK; Chen L; Hou JY; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Accordino MK; Neuget AI; Hershman DL; Wright JD Arch Gynecol Obstet; 2020 Oct; 302(4):935-945. PubMed ID: 32728922 [TBL] [Abstract][Full Text] [Related]
39. Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study. Goldin M; Cohen J; Makhnevich A; Mulvany C; Akerman M; Sinvani L J Thromb Thrombolysis; 2018 Apr; 45(3):369-376. PubMed ID: 29330739 [TBL] [Abstract][Full Text] [Related]
40. Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy. Laws A; Anderson K; Hu J; McLean K; Novak L; Dominici LS; Nakhlis F; Carty M; Caterson S; Chun Y; Duggan M; Barry W; Connell N; Golshan M; King TA Ann Surg Oncol; 2018 Nov; 25(12):3548-3555. PubMed ID: 30128903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]